Abstract:Background Depression is a mental illness characterized by persistent sadness and a reduced capacity for pleasure. In clinical practice, SSRIs and other medications are commonly used for therapy, despite their various side effects. Natural products present distinct advantages, including synergistic interactions among multiple components and targeting multiple pathways, suggesting their tremendous potential in depression treatment. Imbalance in mitochondrial quality control (MQC) plays a significant role in the pathology of depression, emphasizing the importance of regulating MQC as a potential intervention strategy in addressing the onset and progression of depression. However, the role and mechanism through which natural products regulate MQC in depression treatments still need to be comprehensively elucidated, particularly in clinical and preclinical settings. Purpose This review was aimed to summarize the findings of recent studies and outline the pharmacological mechanisms by which natural products modulate MQC to exert antidepressant effects. Additionally, it evaluated current research limitations and proposed new strategies for future preclinical and clinical applications in the depression domain. Methods To study the main pharmacological mechanisms underlying the regulation of MQC by natural products in the treatment of depression, we conducted a thorough search across databases such as PubMed, Web of Science, and ScienceDirect databases to classify and summarize the relationship between MQC and depression, as well as the regulatory mechanisms of natural products. Results Numerous studies have shown that irregularities in the MQC system play an important role in the pathology of depression, and the regulation of the MQC system is involved in antidepressant treatments. Natural products mainly regulate the MQC system to induce antidepressant effects by alleviating oxidative stress, balancing ATP levels, promoting mitophagy, maintaining calcium homeostasis, optimizing mitochondrial dynamics, regulating mitochondrial membrane potential, and enhancing mitochondrial biogenesis. Conclusions We comprehensively summarized the regulation of natural products on the MQC system in antidepressants, providing a unique perspective for the application of natural products within antidepressant therapy. However, extensive efforts are imperative in clinical and preclinical investigations to delve deeper into the mechanisms underlying how antidepressant medications impact MQC, which is crucial for the development of effective antidepressant treatments.

Depression, mitochondrial bioenergetics, and electroconvulsive therapy: a new approach towards personalized medicine in psychiatric treatment - a short review and current perspective

From Early Diagnosis to Emerging Treatment Options

Targeting Inflammatory-Mitochondrial Response in Major Depression: Current Evidence and Further Challenges

Insights into Major Depression as a Mitochondria-Associated Disease

Mitochondrial Dysfunction in the Pathophysiology of Bipolar Disorder: Effects of Pharmacotherapy

Mitochondria in depression: The dysfunction of mitochondrial energy metabolism and quality control systems

Mitochondria, Metabolism, and Redox Mechanisms in Psychiatric Disorders

Mitochondrial Dysfunction as a Biomarker of Illness State in Bipolar Disorder: A Critical Review

A new approach for the treatment of subthreshold bipolar disorders: Targeted high dose levothyroxine and repetitive transcranial magnetic stimulation for mitochondrial treatment

Antidepressant electroconvulsive therapy: Mechanism of action, recent advances and limitations

Pharmacological mechanism of natural antidepressants: The role of mitochondrial quality control

The cellular and molecular basis of major depressive disorder: towards a unified model for understanding clinical depression

Major Depressive Disorder: Advances in Neuroscience Research and Translational Applications

Mitochondrial dysfunction: A fatal blow in depression

Targeting Mitophagy for Depression Amelioration: a Novel Therapeutic Strategy

Mitochondrial modulators in the treatment of bipolar depression: a systematic review and meta-analysis

Energy Metabolism in Major Depressive Disorder: Recent Advances from Omics Technologies and Imaging.

Integrating mitoepigenetics into research in mood disorders: a state-of-the-art review

Effect of desipramine and fluoxetine on energy metabolism of cerebral mitochondria

Serotonin effects on human iPSC-derived neural cell functions: from mitochondria to depression

New and emerging treatments for major depressive disorder